Meningococcal C vaccines: The Canadian experience

Pediatric Infectious Disease Journal

Volumn 23, Issue 12 SUPPL., 2004, Pages

  De Wals, Philippe ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Canada; Cost; Serogroup C meningococcal disease; Vaccine strategies

Indexed keywords

GLYCOCONJUGATE VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTUMN; CANADA; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EPIDEMIC; HUMAN; IMMUNIZATION; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MORBIDITY; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; VACCINATION; AGE; COST BENEFIT ANALYSIS; ECONOMICS; IMMUNOLOGY; MASS IMMUNIZATION; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; CANADA; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MASS IMMUNIZATION; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP C;

EID: 16544379835     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000147643.95195.37     Document Type: Article

References (10)

1. National Advisory Committee on Immunisation. Statement on recommended use of meningococcal vaccines. Can Commun Dis Rep. 2001;27:2-36.
2. Squires SG, Deeks SL, Tsang RS. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001. Can Commun Dis Rep. 2004;30:17-28.
3. Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994. Clin Infect Dis. 1998;26:1159-1164.
4. De Wals P, De Serres G, Niyonsenga T. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec. JAMA. 2001;285:177-181.
5. De Wals P, Erickson L. Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec. Vaccine. 2002;20:2840-2844.
6. De Wals P, Dionne M, Douville-Fradet M, Boulianne N, Drapeau J, De Serres G. Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada. Bull World Health Organ. 1996;74:407-411.
7. De Wals P, Deceuninck G, Boulianne N, De Serres G. Impact of a mass immunization campaign against serogroup C meningococcal disease in 2001-2002, Province of Quebec, Canada. Int J Infect Dis. 2004;8(suppl 1):S190.
8. 7a. De Wals P, Deceuninck G, Boulianne N, De Serres G. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine in Quebec. JAMA. In press.
9. De Wals P, Allard MA, Guindon K, Mayrand L, Simard S, Black R. Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region, Quebec. Can Commun Dis Rep. 2002;28:61-63.
10. De Wals P, Nguyen VH, Erickson LJ, Guay M, Drapeau J, St-Laurent J. Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease. Vaccine. 2004;22:1233-1240.